Title

News

Oxford University scientist developing new treatments to tackle breast cancer that has spread to the brain
Professor Nicola Sibson of the Department of Oncology has been awarded a grant worth almost £200,000 by research charity Breast Cancer Now to fund cutting-edge research to uncover novel treatment combinations to control breast cancer that has spread to the brain. The news comes on Secondary Breast...
 
Worm study reveals role of stem cells in cancer
A new study carried out by the University of Oxford has used flat worms to look at the role of migrating stem cells in cancer. Researchers from the Aboobaker lab in the Department of Zoology used the worms (planarians) which are known for their ability to regenerate their tissues and organs...
 
Congratulations to our new Professor and Associate Professor
Congratulations to: Ester Hammond who has been awarded the title of Professor of Molecular Cancer Biology. Bart Conelissen who has been awarded an Associate Professorship. 
 
Congratulations to student prize winners
The 5th Annual Oncology Student Symposium held at St Anne’s College on Thursday, 13 July was a great success with  a full day of talks in the Mary Ogilvie lecture theatre and a poster session in the marquee within the beautiful surroundings of the St Anne’s Quad.   The judges commented on how high...
 
Oxford science goes to Durham
Runners at the Framwellgate ParkRun got a taste of cancer research with their morning run on Saturday,15 July.  The Department of Oncology teamed up with Framwellgate School (Durham) to reach out to people taking part in the regular 5K run.   The Department's Public Engagament Manager, Martin...
 
Pedals Power Cancer Research
On 17 August, two heroes arrived at the CRUK/MRC Oxford Institute for Radiation Oncology by bike after a journey of 850 miles. Sue Duncombe and Patrick McGuire arrived bearing £6000 of funding which they raised by cycling 850 miles from the CRUK Cambridge Research Institute to the Oxford Institute...
 
Oxford Professor receives Honorary Degree from the Institute of Cancer Research
It was announced in February this year that Professor Adrian Harris has been awarded an Honorary Degree of Doctor of Science (Medicine) of the University of London from the Institute of Cancer Research in recognition of his outstanding contribution to cancer research and treatment.  Pictured: ...
 
A UNIQ course - Oncology welcomes tomorrow's scientists
  On Monday, 24 July the Department of Oncology will welcome 27 students from across the UK who will gather in Oxford to find out what it would be like to study here.  During the week the students will live in college accommodation, eatin the halls, experience student life and discover the science...
 
Oxford collaborative science opens the way for a new drug for bowel cancer patients across the UK
Today a new drug will become available for patients with bowel cancer as part of a national clinical trial; based on a scientific discovery made only two years ago at the University of Oxford. A yeast genetics research group led by Professor Tim Humphrey in Oxford discovered an Achilles heel of...
 
Medical Research Council - Festival of Medical Research.
Members of the Department of Oncology will be out and about in the community over the next week or so explaining how your tax money is used to fund ground breaking medical research in Oxford.  Scientists from all over the world work together to tackle cancer, eczema, and aenemia.  Your genes play...
 
Green Impact Team silver award
Congratultions to everyone in Old Road Campus Research Building’s Green Impact team, which includes various members of staff from Departments within the Building including Oncology, and also to everyone in the building who has helped achieve a silver award for environmental sustainability projects...
 
Researchers make breakthrough discovery in fight against colorectal cancer
New research led by Queen’s University Belfast in collaboration with the University of Oxford, has discovered how a genomic approach to understanding colorectal cancer could improve the prognosis and quality of life for patients. For clinicians, treating patients with bowel cancer can be...
 
FOXFIRE Combined Analysis
FOXFIRE Combined Analysis indicates no benefit in overall survival from adding selective internal radiotherapy [SIRT] to first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer. Secondary analyses confirm improved control of liver metastases with liver-directed SIRT and show...
 
Video makers visit the Department of Oncology
Last September, a challenge went out to schools to make a two-minute video to explain our science to the public. Over 30 teams of students rose to the challenge.  On 5 April, the top six entries visited the Department of Oncology to collect their prizes and take advantage of the opportunity to...
 
Cancer Research UK Boat Race
Joshua Bugajski (Stroke 4), an MSc Oncology student in Katherine Vallis’ group was part of Oxford’s winning team on Sunday, 2 April when they cruised to victory in the 2017 Cancer Research UK boat race against Cambridge.  Oxford won the toss and chose the Surrey station.  The crew took an early...
 
Cancer Research UK Boat Race
 
New era in precision medicine for pancreatic cancer
 
Super Science
 
Oxfordshire Apprenticeship Awards
 
Super Science Saturday: curing the brain
 
Girls do physics: physics cures cancer
 
Bubbles, ultrasound and radiotherapy: creating a new approach to drug delivery
 
2016 Advanced Apprenticeship Award
 
Gold nanoparticles help deliver lethal one-two punch to cancer
 
Environmental sustainability
 
University of Oxford researchers awarded more than £140,000 to develop new techniques to detect pancreatic cancer
 
Oxford talking about Stand up to Cancer
 
About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
Research
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate and postdoctoral training programmes for both scientists and clinicians are internationally recognised.